Physiological formation of 8-epi-PGF2 alpha in vivo is not affected by cyclooxygenase inhibition.

Advances in prostaglandin, thromboxane, and leukotriene research

Volumn 23, Issue , 1995, Pages 233-236

  Catella, F ^a   Reilly, M P ^a   Delanty, N ^a   Lawson, J A ^a   Moran, N ^a   Meagher, E ^a   FitzGerald, G A ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; MONOUNSATURATED FATTY ACID; OXYGEN; PARACETAMOL; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR; SATIGREL;

ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; MASS FRAGMENTOGRAPHY; METABOLISM; RANDOMIZED CONTROLLED TRIAL; SMOKING; URINE;

ACETAMINOPHEN; ASPIRIN; CROSS-OVER STUDIES; CYCLOOXYGENASE INHIBITORS; DINOPROST; DOUBLE-BLIND METHOD; FATTY ACIDS, MONOUNSATURATED; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; OXYGEN ISOTOPES; PLATELET AGGREGATION INHIBITORS; SMOKING;

EID: 0029204990     PISSN: 07328141     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)